Our proprietary biological age clock enables you to demonstrate product efficacy with quantitative, clinically robust evidence - giving you the scientific credibility needed for regulators, investors, and consumers.
We conduct targeted clinical trials with up to 60 participants, measuring biological age at three key points:
◎ Baseline before treatment
◎ After 3 months of product use
◎ 3 months after that without treatment
Our unique design not only proves whether a product reduces biological age but also shows whether the effect is sustained or reversible.
Our platform advances beyond existing methylation clocks by improving the DeepMAgemodel with higher accuracy and clinical reliability.
This technology enables us to deliver results that are both scientifically rigorous and commercially powerful.
Epix AI collaborates with leading Clinical Research Organizations to clinically test the health claims of longevity products.
We use our own biological age clock, built around state of the art research to test products’ effect on biological age and on specific domains of human health.
Epix AI employs exhaustive DNA and epigenetic tests that give us detailed information about the products’ effects at genetic and epigenetic level.
DNA methylation clocks like EPIX.AI are recognized as:
○ Early-response biomarkers, detecting changes before traditional markers
○ Mechanistically tied to core hallmarks of aging (e.g., inflammation, cellular senescence, DNA repair)
○ Sensitive and actionable tools to determine whether interventions can slow, halt, or reverse aging
This means your products can be backed by clear, scientific proof. Not just marketing claims.
By collaborating with EPIX.AI, your company gains more than just trial data:
➤ Clinical Proof: Robust evidence to strengthen marketing, regulatory, and investor narratives
➤ Novel Biomarker Insights: Expand your IP portfolio and open doors for publications
➤ Market Differentiation: Position your business as a scientific leader in the longevity and personalized wellness markets
➤ Personalization: Future potential for individual supplement response insights to DNA methylation signatures
We provide end-to-end support, including:
🧬 Clinical trial design
🧬 Biomarker and DNA methylation analysis
🧬 Statistical evaluation and interpretation
🧬 Full scientific reports + concise executive summaries (tailored for R&D, regulatory submissions, investors, and marketing teams)
Get in touch with us to validate your longevity claims with science.